Persistent Genital Arousal Disorder, or PGAD, can cause unwanted genital arousal sensations, tingling, throbbing, pressure, burning, sensitivity, pelvic discomfort, or genito-pelvic dysesthesia without sexual desire. A diagnosis-first evaluation helps determine whether symptoms may be related to pelvic nerve irritation, pudendal neuralgia, pelvic floor dysfunction, spine or sacral nerve issues, autonomic symptoms, medication history, musculoskeletal mechanics, or overlapping chronic pelvic pain conditions.
Learn how Dr. Ahmed explains Persistent Genital Arousal Disorder (PGAD), explores its potential underlying causes, and discusses personalized treatment options to help patients find relief.
Our team organizes conditions and treatments into related zones of expertise to make it easier to explore the care paths most relevant to your symptoms and goals.
Use the zone tags above to browse dedicated pages for each focus area, including services, providers, and what to expect during treatment.
If you feel persistent genital sensation or arousal that won’t go away — even when you don’t want it to — you are not alone, and it may be a real medical condition.
Persistent Genital Arousal Disorder, or PGAD, is a condition where people experience ongoing unwanted sensations of arousal, pressure, throbbing, tingling, or sensitivity that can become extremely distressing and disruptive.One of the hardest parts about PGAD is that many patients feel embarrassed to talk about it, or are told it’s “just anxiety” or psychological. But in many cases, there can be very real physical contributors.
Symptoms can sometimes be related to the pelvic floor muscles, nerve irritation, spinal issues, Tarlov cysts, pudendal neuralgia, vascular conditions, or nervous system sensitization.And because the nervous system and pelvic floor are so closely connected, the body can get stuck in a cycle where muscles tighten, nerves become more sensitive, and symptoms continue reinforcing themselves.
That’s why my approach is always to look at the whole picture. We evaluate the pelvic floor, nervous system, spine, biomechanics, and any overlapping conditions that may be contributing to symptoms.
Treatment is individualized and may include pelvic floor therapy, nervous system regulation, medications, movement-based treatment, injections, or coordination with additional specialists when needed.
Most importantly, I want patients to know that this condition is real, and you deserve compassionate, thoughtful care without shame or judgment.
Persistent Genital Arousal Disorder, often called PGAD, is a distressing genito-pelvic sensory condition involving persistent, unwanted genital arousal sensations that are not connected to sexual desire. Symptoms may include genital tingling, throbbing, pressure, burning, sensitivity, fullness, pelvic discomfort, or sensations that feel difficult to ignore or relieve.
PGAD can be deeply disruptive and emotionally distressing. Many patients feel embarrassed, dismissed, or misunderstood, especially when symptoms are incorrectly treated as psychological, sexual, or behavioral rather than medical and sensory.
At Manhattan Pain Medicine (MPM), PGAD is evaluated through a diagnosis-first lens. The goal is to understand whether symptoms may be related to pudendal nerve irritation, pelvic floor dysfunction, pelvic dystonia, sacral nerve root irritation, disc herniation, sciatica-like nerve pain, small fiber neuropathy, autonomic dysfunction, medication changes, endometriosis, fibroids, SI joint dysfunction, hip impingement, hypermobility, EDS, MCAS, or chronic pain sensitization.
For patients looking for PGAD treatment in Manhattan or NYC, MPM provides a discreet, medically respectful evaluation of unwanted genital arousal sensations, genital dysesthesia, pelvic nerve pain, pudendal-type pain, pelvic floor dysfunction, sacral nerve symptoms, chronic pelvic pain, and overlapping musculoskeletal or autonomic contributors.
MPM reviews symptom location, triggers, sitting tolerance, pelvic floor symptoms, bowel and bladder symptoms, sexual pain, medication changes, antidepressant or withdrawal history, pelvic floor therapy response, gynecology or urology history, spine symptoms, sacral pain, hip pain, SI joint pain, hypermobility, autonomic symptoms, small fiber neuropathy symptoms, prior imaging, and prior treatment response.
Care may involve pelvic floor therapy coordination, medication management, pain psychology, biofeedback, acupuncture, Feldenkrais, diagnostic ultrasound when appropriate, ultrasound-guided injections, pelvic floor trigger point injections, pudendal nerve block, peripheral nerve blocks, ganglion impar block, superior hypogastric plexus block, sympathetic blocks, nerve hydrodissection, neuromodulation in selected refractory cases, or coordination with gynecology, urology, neurology, sexual medicine, pelvic floor therapy, psychiatry, rheumatology, vascular, or spine specialists when needed.
PGAD is not a sexual desire disorder. Patients may experience persistent genital arousal sensations, genital tingling, pressure, throbbing, burning, or sensitivity without wanting sexual activity and without feeling emotionally or psychologically aroused.
This distinction matters. PGAD symptoms can be confusing and distressing because the body may produce sensory signals that do not match the patient’s emotional state, intention, or desire. Symptoms may be triggered or worsened by sitting, pressure, movement, stress physiology, pelvic floor muscle tension, nerve irritation, medication changes, spine issues, or autonomic nervous system factors.
MPM approaches PGAD as a medical, sensory, pelvic pain, and nervous system condition that deserves careful evaluation without shame or dismissal.
PGAD fits within MPM’s Pelvic Pain, Musculoskeletal issues, and Autonomic dysfunction Zones of Expertise because unwanted genital arousal sensations may overlap with pelvic nerve pain, pelvic floor dysfunction, pudendal neuralgia, sacral nerve irritation, SI joint dysfunction, hip mechanics, spine-related nerve symptoms, and autonomic nervous system changes.
For some patients, hypermobility spectrum disorder, Ehlers-Danlos syndrome, small fiber neuropathy, MCAS, or dysautonomia may add complexity. MPM evaluates these relationships carefully without assuming that every PGAD symptom is caused by one condition or one finding.
I cannot say enough good things about Manhattan Pain Medicine. From the moment I walked in, I felt truly cared for and taken seriously. Dr. Nino Mikaberidze, Director of Rheumatology, is exceptional — knowledgeable, compassionate, and incredibly thorough. She takes the time to listen, explains every...
The best care I've received as a chronic pain patient. I traveled from out of state to visit Manhattan Pain Medicine because I could not find knowledgeable doctors in my hometown for my hypermobility, and Ehlers-Danlos syndrome symptoms and comorbidities. Let me tell you, it was worth every travel e...
I was injured in a bicycle accident over 8 years ago. I’ve suffered throughout the years since my accident with nothing seeming to work. PT, Yoga, lifestyle changes, NOTHNG! I finally made an appointment with Dr Kane and I’m feeling an improvement in my life. I no longer stay up all night in pain, a...
One of the best experiences, if not the best, I have ever had at the doctor’s office. From the front desk to the nurses to the PA assisting the doctor this was a great experience. Dr.Nino actually listened to me and came up with a game plan. Would recommend this practice to as many people as I could...
I have very unique & severe nerve pain from CRPS which has no known specific cure. Dr. Siefferman has a huge tool box, far greater than the other 23 Drs. I have seen. He saved me from jumping off a bridge and continues to help me with both treatments and advice. Dr. S. is in a different league!
After two years of searching and feeling lost and let down, I finally found real help at Manhattan Pain Medicine. With Dr. Siefferman, Adam Rosenberg, Dr. Mikaberidze, and the whole team, I feel heard, supported and understood. Every symptom is being considered and I’m finally getting answers with m...
Why is Dr Dr. Tayyaba Ahmed one of the top pevic Floor specialists - 1- She wants to know a full history of what led the patient to get to this point. 2 - She listens intensley to the patient 3- She does not rush you 4- Extremely skilled at giving pelvic floor injections 5- I thank my luck stars she...
The staff was friendly and helpful. Dr. Siefferman was thoughtful, listened, asked questions and proposed simple safe ways to come to further conclusions regarding my pain and discomfort. The office staff including Dr. Siefferman is responsive even after the initial in-person visit. Very pleased.
Dr. Siefferman is a brilliant provider. While my pain is still a work in progress, Dr Siefferman always gives me options and explains his reasoning behind things. He listens to my feedback and concerns. I never feel rushed; and am grateful he works to meet me where I am. I highly recommend him.
What a great find! They listen to me, I listen to them and the diagnosis is made and a plan developed to develop an approach to treat all of my chronic pain. I wish I could have discovered this type of treatment sooner. This doctor and group give me hope.
Persistent Genital Arousal Disorder, or PGAD, is a condition involving persistent or recurring unwanted genital arousal sensations that are not connected to sexual desire. Symptoms may include genital tingling, throbbing, pressure, burning, sensitivity, pelvic discomfort, or genito-pelvic dysesthesia.
No. PGAD is not the same as sexual desire. Patients may experience unwanted genital sensations without emotional arousal, sexual interest, or desire. This distinction is important because PGAD is a medical and sensory condition, not a reflection of intention or behavior.
PGAD may feel like persistent genital tingling, throbbing, pressure, burning, pulsing, sensitivity, fullness, or arousal-like sensations that feel intrusive, distressing, or difficult to relieve. Some patients also have pelvic pain, pudendal-type pain, sitting pain, bladder symptoms, bowel symptoms, or pelvic floor tightness.
Yes. PGAD can involve genital dysesthesia, which means abnormal or uncomfortable sensations in the genital or pelvic region. Symptoms may include tingling, burning, pressure, throbbing, sensitivity, or arousal-like sensations without sexual desire.
Yes. Pelvic floor dysfunction, pelvic floor muscle overactivity, pelvic dystonia, or pelvic trigger points may contribute to PGAD-like symptoms in some patients. Pelvic floor muscle tension can irritate pelvic nerves and may increase genital or pelvic sensory symptoms.
Pudendal nerve irritation may contribute to genital burning, tingling, pressure, sensitivity, sitting pain, rectal pain, perineal pain, or arousal-like sensations in selected patients. PGAD and pudendal neuralgia can overlap, but one does not automatically prove the other.
In some patients, sacral nerve irritation, disc herniation, sciatica-like nerve pain, Tarlov cysts, or other spine-related findings may overlap with PGAD-like symptoms. These findings require careful clinical correlation because imaging findings do not always explain symptoms by themselves.
Yes. Small fiber neuropathy and autonomic dysfunction may contribute to burning, tingling, temperature sensitivity, abnormal sensations, dysautonomia, pelvic discomfort, or sensory amplification in some patients. PGAD-like symptoms can also overlap with MCAS, hypermobility, EDS, and chronic pain sensitization.
Medication changes, including changes in antidepressants or medication withdrawal, have been reported as possible triggers in some PGAD cases. A careful medication history is important, but medication changes should only be made with clinician supervision.
Evaluation may include a detailed symptom history, pelvic pain mapping, pelvic floor symptom review, medication history, sexual pain history, bowel and bladder review, neurologic symptom review, spine and sacral symptom assessment, imaging review, and evaluation for pudendal neuralgia, pelvic floor dysfunction, small fiber neuropathy, autonomic symptoms, gynecologic conditions, and musculoskeletal contributors.
Treatment depends on the likely contributors. Options may include pelvic floor therapy coordination, medication management, pain psychology, biofeedback, acupuncture, Feldenkrais, pelvic floor trigger point injections, pudendal nerve block, peripheral nerve blocks, ganglion impar block, superior hypogastric plexus block, sympathetic blocks, nerve hydrodissection, lidocaine or ketamine-related treatments, or neuromodulation in selected refractory cases.
These options may be considered when evaluation suggests a specific pelvic nerve, pelvic floor, sympathetic, sacral, or chronic pain pathway target. They are not routine treatments for every PGAD patient and require careful diagnosis, risk discussion, target selection, and coordination with the broader care plan.
Pain psychology and biofeedback may help some patients manage distress, nervous system reactivity, fear, sleep disruption, and symptom amplification. This does not mean PGAD is “all psychological.” These tools can support nervous system regulation while medical contributors are evaluated and treated.
PGAD-related symptoms require urgent support if there are suicidal thoughts, severe distress with inability to function, fever, severe or sudden pelvic or abdominal pain, heavy bleeding, pregnancy-related pain, fainting, blood in urine or stool, inability to urinate, new bowel or bladder dysfunction, saddle anesthesia, new leg weakness, unexplained weight loss, severe testicular pain, signs of infection, chest pain, shortness of breath, or rapidly worsening symptoms.
Before care begins, our team helps patients understand the practical side of treatment, including insurance verification, out-of-network benefits, cost-share estimates, self-pay options, and billing questions. We believe patients should have as much clarity as possible before moving forward.
If unwanted genital arousal sensations, genital tingling, pressure, burning, pelvic discomfort, pudendal-type pain, pelvic floor symptoms, or genito-pelvic dysesthesia is affecting your daily life, MPM can help evaluate what may be contributing. Our diagnosis-first approach considers pelvic nerve pain, pudendal neuralgia, pelvic floor dysfunction, pelvic dystonia, spine or sacral nerve issues, medication history, autonomic symptoms, small fiber neuropathy, endometriosis, fibroids, hip and SI joint mechanics, hypermobility, EDS, MCAS, and chronic pain mechanisms. Request an appointment to discuss your symptoms in a discreet, medically respectful setting.
Jason W. Siefferman, MD
Jason W. Siefferman, MD
MPM
Persistent Genital Arousal Disorder, often abbreviated PGAD, is a genito-pelvic sensory condition involving persistent, unwanted genital arousal sensations that are not connected to sexual desire. Symptoms may include genital tingling, throbbing, pressure, burning, fullness, sensitivity, pulsing, discomfort, or arousal-like sensations that feel intrusive or difficult to relieve.
PGAD can be physically uncomfortable and emotionally distressing. Many patients feel isolated because the symptoms are private, difficult to describe, and often misunderstood. Some patients have been dismissed or told the symptoms are purely psychological, even when there may be pelvic nerve, pelvic floor, spine, autonomic, medication-related, or chronic pain contributors.
MPM approaches PGAD with discretion, clinical precision, and respect. The goal is to understand the symptom pattern, identify possible drivers, coordinate care, and create a treatment plan based on the likely pain or sensory generator.
PGAD is not the same as sexual desire. A patient may experience genital arousal-like sensations without wanting sexual activity and without feeling emotionally or psychologically aroused. The sensations may be persistent, intrusive, unwanted, and distressing.
This distinction is essential. PGAD should not be framed as a behavioral issue, moral issue, or sexual desire issue. It is better understood as a genito-pelvic sensory condition that may involve nerves, muscles, medications, autonomic function, chronic pain pathways, or multiple overlapping contributors.
PGAD symptoms vary by patient. Some describe tingling, throbbing, pulsing, pressure, swelling sensations, burning, heightened sensitivity, pelvic discomfort, or persistent genital arousal sensations. Others describe pain, dysesthesia, urinary discomfort, bowel symptoms, sitting intolerance, or pelvic floor tightness.
Symptoms may involve the clitoris, vulva, vagina, penis, scrotum, perineum, rectum, pelvis, bladder, urethra, buttocks, sacrum, or inner thighs. Symptoms may worsen with sitting, pressure, stress physiology, movement, certain clothing, sexual activity, bowel movements, urination, medication changes, or flares of pelvic pain.
The term genito-pelvic dysesthesia is sometimes used because many patients experience abnormal genital or pelvic sensations rather than true arousal. Dysesthesia means an abnormal, unpleasant, or uncomfortable sensation.
Pelvic nerve irritation may contribute to these sensations in some patients. The pudendal nerve, sacral nerve roots, peripheral pelvic nerves, and autonomic pathways may all be considered depending on the symptom pattern. This does not mean every case of PGAD is caused by a nerve entrapment, but nerve-related contributors should be evaluated when symptoms suggest them.
PGAD can overlap with pudendal neuralgia. The pudendal nerve carries sensation from parts of the perineum, genitals, and rectal region. When irritated or sensitized, it may contribute to burning, tingling, electric pain, pressure, hypersensitivity, rectal pain, genital pain, or sitting-related symptoms.
Some patients with pudendal neuralgia-like symptoms also report arousal-like sensations. Others have pelvic floor muscle overactivity that irritates the pudendal nerve. MPM evaluates the nerve pattern, pelvic floor pattern, sitting triggers, sensory distribution, prior pelvic therapy response, and possible musculoskeletal contributors before recommending treatment.
Pelvic floor dysfunction can contribute to PGAD-like symptoms in selected patients. When the pelvic floor muscles are overactive, tight, poorly coordinated, or unable to relax, they may increase pressure around pelvic nerves and soft tissues.
Patients may experience pelvic tightness, spasms, burning, pressure, painful intercourse, constipation, urinary urgency, bladder discomfort, or pain with sitting. Pelvic floor therapy may help some patients, but if symptoms persist, it is important to evaluate whether there are additional contributors such as pudendal nerve irritation, sacral nerve involvement, SI joint dysfunction, hip impingement, endometriosis, fibroids, or small fiber neuropathy.
Pelvic dystonia refers to involuntary or dystonia-like pelvic floor muscle overactivity. In some patients, pelvic muscle spasm and difficulty relaxing may contribute to unwanted genital sensations, pelvic pain, pressure, burning, urinary symptoms, bowel symptoms, or sexual pain.
Pelvic dystonia may be primary or reactive. It can develop in response to chronic pelvic pain, pudendal nerve irritation, endometriosis, fibroids, constipation, hip pain, SI joint pain, trauma, surgery, childbirth, or hypermobility-related pelvic mechanics.
PGAD-like symptoms may overlap with spine or sacral nerve issues in selected patients. Sacral nerve roots help carry sensory signals from the pelvis and genital region. Irritation in this region may contribute to abnormal pelvic or genital sensations.
Disc herniations, sciatica-like symptoms, sacral nerve irritation, Tarlov cysts, tethered cord concerns, or other spine-related findings may be considered when symptoms include low back pain, sacral pain, leg symptoms, numbness, tingling, bowel or bladder changes, or positional flares.
Imaging findings require careful interpretation. A disc finding, cyst, or other structural change does not automatically prove the cause of PGAD, but it may be relevant when symptoms and exam findings align.
Small fiber neuropathy can affect sensory and autonomic small nerve fibers. In some patients, this may contribute to burning, tingling, temperature sensitivity, abnormal sensations, autonomic symptoms, bowel or bladder changes, sweating changes, dizziness, heart rate symptoms, or widespread sensory amplification.
PGAD-like symptoms may also overlap with autonomic dysfunction, MCAS, hypermobility, EDS, and chronic pain sensitization. These relationships are complex and should be evaluated carefully rather than assumed.
Medication changes have been reported as possible triggers in some PGAD cases, including changes involving antidepressants or medication withdrawal. Medication history matters because nervous system symptoms can shift after starting, stopping, or changing certain medications.
Patients should not stop or change medications without clinician supervision. MPM reviews medication history as part of the broader evaluation and coordinates with the prescribing clinician, psychiatry, primary care, neurology, or other specialists when appropriate.
Endometriosis and fibroids can overlap with pelvic floor dysfunction, pelvic nerve irritation, pelvic pain, painful intercourse, bowel symptoms, bladder symptoms, and chronic pelvic sensitization. In some patients, these conditions may coexist with PGAD-like symptoms or increase pelvic floor guarding.
MPM does not replace gynecology or gynecologic treatment. Instead, MPM evaluates pain and sensory contributors that may persist alongside gynecologic conditions, including pudendal neuralgia, pelvic floor dysfunction, SI joint dysfunction, hip impingement, sacral nerve irritation, abdominal wall pain, and chronic pain mechanisms.
The pelvis functions as a connected system. Sacroiliac joint dysfunction, hip impingement, anterior pelvic tilt, pelvic instability, chronic constipation, muscle guarding, and altered gait can all influence pelvic floor tone and pelvic nerve sensitivity.
For some patients, the genital symptoms are part of a broader pelvic pain pattern that also includes hip pain, buttock pain, low back pain, SI joint pain, tailbone pain, or sitting intolerance. MPM evaluates these contributors together rather than treating PGAD in isolation.
In selected patients, hypermobility spectrum disorder or Ehlers-Danlos syndrome may contribute to pelvic mechanics, SI joint instability, hip instability, ligamentous strain, protective muscle guarding, and nerve sensitivity. These factors may increase the complexity of pelvic pain and genito-pelvic symptoms.
This does not mean that every patient with PGAD has hypermobility or EDS. MPM considers these diagnoses when the history suggests joint instability, recurrent injuries, pelvic instability, dysautonomia, MCAS-like symptoms, or widespread connective tissue-related pain.
PGAD is often misunderstood because symptoms are private, difficult to describe, and easily mischaracterized. Patients may feel ashamed or afraid to bring up symptoms. Some may avoid care because they worry they will not be believed.
A medically respectful evaluation is important. PGAD symptoms should be taken seriously, assessed discreetly, and evaluated in the context of pelvic nerve function, pelvic floor mechanics, spine and sacral nerve pathways, medication history, autonomic symptoms, chronic pelvic pain, and psychological distress.
MPM begins with a detailed symptom map. This includes the location of sensations, quality of symptoms, triggers, duration, sitting tolerance, pelvic pain, sexual pain, bladder symptoms, bowel symptoms, pelvic floor therapy history, medication history, antidepressant changes, spine symptoms, sacral symptoms, hip pain, SI joint symptoms, gynecologic history, prior imaging, prior procedures, and prior treatment response.
The evaluation may consider pudendal neuralgia, pelvic floor dysfunction, pelvic dystonia, anterior pelvic tilt, sacroiliac joint dysfunction, hip impingement, May Thurner Syndrome, Nutcracker Syndrome, chronic constipation, enthesitis, EDS, hypermobility spectrum disorder, sciatica and herniated discs, disc herniations, endometriosis, fibroids, small fiber neuropathy, MCAS, autonomic dysfunction, medication effects, and chronic pain sensitization.
Treatment depends on the diagnosed contributors. Some patients may benefit from pelvic floor therapy coordination, medication management, pain psychology, biofeedback, acupuncture, Feldenkrais, bowel or bladder coordination, medication review, and treatment of contributing hip, SI joint, spine, gynecologic, or musculoskeletal drivers.
Selected patients may be considered for pelvic floor trigger point injections, pudendal nerve block, peripheral nerve blocks, nerve hydrodissection, ganglion impar block, superior hypogastric plexus block, lumbar sympathetic blocks, sympathetic blocks, epidural injections, lidocaine or ketamine-related treatments, peripheral nerve stimulation, dorsal root ganglion stimulation, spinal cord stimulation, or other neuromodulation approaches. These options are not routine for every patient.
A pudendal nerve block may be considered when symptoms suggest pudendal nerve irritation or pudendal neuralgia overlap. The procedure may help clarify whether the pudendal nerve is contributing to symptoms and may provide temporary relief in selected patients.
A nerve block is not a cure for PGAD and is not appropriate for every patient. It should be considered only after careful evaluation of the nerve distribution, pelvic floor symptoms, spine and sacral contributors, and treatment goals.
Pelvic floor trigger point injections may be considered when focal pelvic floor muscle trigger points, spasm, or overactivity are contributing to pain or sensory symptoms. These injections may be used as part of a broader plan that includes pelvic floor therapy, movement retraining, medication management, or pain psychology.
They are not a universal treatment for PGAD and should only be used when the clinical pattern supports a pelvic floor muscle target.
Neuromodulation options, such as peripheral nerve stimulation, dorsal root ganglion stimulation, or spinal cord stimulation, may be considered in selected refractory cases when symptoms are persistent, severe, and linked to a defined nerve or pain pathway.
These treatments require careful selection, risk discussion, and coordination. They are not first-line treatment for most patients and should not be presented as guaranteed solutions.
PGAD can create significant distress, anxiety, shame, sleep disruption, fear, and functional impairment. Pain psychology and biofeedback can help support nervous system regulation, coping strategies, distress reduction, and symptom management.
This does not mean PGAD is purely psychological. Psychological support can be part of comprehensive medical care for a condition that affects the pelvic nerves, pelvic floor, autonomic nervous system, and chronic pain pathways.
Patients should seek urgent support if PGAD symptoms are associated with suicidal thoughts, severe distress with inability to function, or concern for self-harm. Immediate support is also needed for fever, severe or sudden pelvic or abdominal pain, heavy bleeding, pregnancy-related pain, fainting, blood in urine or stool, inability to urinate, new bowel or bladder dysfunction, saddle anesthesia, new leg weakness, unexplained weight loss, severe testicular pain, signs of infection, chest pain, shortness of breath, or rapidly worsening symptoms.
These symptoms may indicate medical, neurologic, gynecologic, urologic, gastrointestinal, vascular, infectious, or emergency conditions that require timely evaluation.
MPM approaches PGAD through a discreet, diagnosis-first, trauma-informed, and coordinated care model. The goal is to identify whether symptoms are driven by pelvic nerve irritation, pudendal neuralgia, pelvic floor dysfunction, pelvic dystonia, sacral nerve irritation, spine-related pain, medication changes, autonomic symptoms, small fiber neuropathy, endometriosis, fibroids, hip or SI joint mechanics, hypermobility, EDS, MCAS, or chronic pain sensitization.
For patients looking for persistent genital arousal disorder treatment in Manhattan or NYC, MPM offers a careful pain medicine perspective focused on symptom mapping, pelvic nerve assessment, pelvic floor collaboration, musculoskeletal evaluation, medication history review, image-guided procedures when appropriate, pain psychology support, and coordination with the right specialists. Treatment is individualized and selected only after the likely contributors are better understood.
